| Project/Area Number |
12210006
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research on Priority Areas
|
| Allocation Type | Single-year Grants |
|---|
| Review Section |
Biological Sciences
|
|---|
| Research Institution | University of Tokyo |
|---|
Principal Investigator |
IWATSUBO Takeshi University of Tokyo, School of Pharmaceutical Sciences, Department of Neuropathology and Neuroscience, Professor, 大学院薬学研究科, 教授 (50223409)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
富田 泰輔 東京大学, 大学院・薬学系研究科, 講師 (30292957)
長谷川 成人 東京大学, 大学院・薬学系研究科, 講師 (10251232)
|
|---|
| Project Period (FY) |
2000 – 2004
|
| Project Status |
Completed (Fiscal Year 2004)
|
| Budget Amount *help |
¥108,900,000 (Direct Cost: ¥108,900,000)
Fiscal Year 2004: ¥26,400,000 (Direct Cost: ¥26,400,000)
Fiscal Year 2003: ¥26,400,000 (Direct Cost: ¥26,400,000)
Fiscal Year 2002: ¥26,400,000 (Direct Cost: ¥26,400,000)
Fiscal Year 2001: ¥29,700,000 (Direct Cost: ¥29,700,000)
|
|---|
| Keywords | Parkinson's disease / a-synuclein / Lewy body / phosphorylation / ubiquitination / neuronal death / 神経科学 / 脳神経疾患 / 老化 / αシヌクレイン / Lewy小体痴呆症 / 神経変性疾患 / Lewy小体型痴呆症 / α-Synuclein |
|---|
| Research Abstract |
To elucidate the molecular pathogenesis of sporadic Parkinson's disease (PD) and dementia with Lewy bodies (DLB), we examined the alterations, especially posttranslational modifications, of α-synuclein (aS) that gets deposited in affected neurons of PD and DLB as fibrillary aggregates represented by Lewy bodies (LB). We analyzed aS purified from insoluble fractions of DLB cortices and demonstrated by mass spectrometry that Ser129 of deposited aS is phosphorylated. Phosphorylated Ser129-specific antibody revealed extensive deposition of aS as intracellular inclusions like LBs, as well as thread-or dot-like deposits in degenerating neurites. A fraction of phosphorylated aS was mono-ubiquitinated at the N- terminal Lys residues. Proteinase K digestion of aS filaments showed that the mid-portion of aS comprises the protease-resistant core structure. Transgenic Drosophila expressing aS in neurons exhibited phosphorylation of aS in a subset of neurons. Co-expression of aS and synphilin-1 in mammalian cultured cells showed that phosphorylation of aS at Ser129 contributes to aggregate formation and cell death. Based on these results, we seek to develop therapeutic strategies to prevent neuronal death in PD or DLB, by inhibiting noxious post-translational modification of aS and other pathogenic proteins.
|
